Ultragenyx Receives PRIME Designation from European Medicines Agency (EMA) for GTX-102 for the Treatment of Angelman Syndrome
https://ir.ultragenyx.com/news-rele...s-prime-designation-european-medicines-agency
Ann: Completion of enrolment in Neuren's Angelman P2 trial, page-39
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.79 |
Change
0.570(2.82%) |
Mkt cap ! $2.671B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $21.10 | $20.39 | $4.076M | 196.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 245 | $20.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.79 | 74 | 6 |
View Market Depth
| Last trade - 12.51pm 26/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |